Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Live Discussions
Live Discussions

Updated 6 November 2009

The Role of Insulin Resistance in Brain Aging and Dementia


Suzanne Craft

Matthew Townsend

Jose Luchsinger

Anyone gazing into a crystal ball about the future health status of Americans should be quite worried about the rapid rise of obesity, diabetes, and related metabolic disorders. Not only do these conditions impose a large direct burden on the nation's health care, but they also greatly increase the risk of dementia, according to a growing body of evidence.

Hyperinsulinemia and insulin resistance increase the risk of Alzheimer disease as well as of vascular dementia. Numerous studies point to a variety of possible mechanisms, including the role of insulin signaling on amyloid-β regulation, synaptic integrity, inflammation tau phosphorylation, brain vascular function, and energy metabolism.

These findings suggest that early identification and treatment of insulin resistance may delay or prevent Alzheimer disease and vascular dementia. Potential interventions include physical exercise, caloric restriction, manipulation of the diet, pharmacologic insulin sensitization, and intranasal delivery of insulin to the brain.

In this Webinar, Suzanne Craft reviewed the evidence on the role of insulin resistance in brain aging and dementia, and presented results from animal and clinical studies of interventions. Joining her for a panel discussion were Greg Cole, Suzanne de la Monte, Bill Klein, Matt Townsend, Jose Luchsinger, and Caroline Sanz.

See Related News:
The Picture of Health? Aging Better—On Fewer Calories
Paris: Diabetes, Insulin, and Alzheimer Disease
Special Issue Explores Link Between Metabolic Disease and Dementia
Keystone: Longevity, Insulin-like Growth Factor Signaling, and Aβ Toxicity
Type 2 Diabetes and Neurodegeneration—The Plot Caramelizes
Research Brief: Diabetes—Risk Factor That Slows Cognitive Decline?

View/Listen to the Webinar
Click on this image to launch the recording.

View Comments By:
Glyn Wainwright — Posted 10 February 2011
Amy Duffield — Posted 14 April 2011


Q&A

Question From Greg Cole
Given that diabetes/insulin resistance appears to be a larger risk factor for dementia in ApoE3 carriers, wouldn't you expect that the patients in your ACT cohort study with Dr. Larson who had both dementia and diabetes/insulin resistance were more likely to be ApoE3 than ApoE4 than the control AD group. That would help explain reduced amyloid pathology. Did you look at ApoE genotype differences?

Reply by Suzanne Craft
That is a logical prediction. Unfortunately, we did not have ApoE genotypes available for our cases to examine this possibility.



Comments on Live Discussion
  Comment by:  Glyn Wainwright
Submitted 10 February 2011  |  Permalink Posted 10 February 2011

Looks like we have a hypothesis based on published research.

References:
Seneff S, et al, Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet, Eur J Intern Med (2011).

View all comments by Glyn Wainwright

  Comment by:  Amy Duffield
Submitted 14 April 2011  |  Permalink Posted 14 April 2011

Given the following facts:

There is an association between insulin resistance and Alzheimer's disease, magnesium helps regulate insulin, and intracellular Mg concentration has been shown to offset calcium-related excitation-contraction coupling.... Has anyone done any research on magnesium in Alzheimer's patients with ApoE3?

Low Mg levels are also being implicated in autism.

View all comments by Amy Duffield

  Submit a Comment on this Live Discussion
Cast your vote and/or make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.

View Webinar Instructions

Early Detection Survey Results
The Alzheimer Disease Early Detection Surveys were designed to gauge perceptions and knowledge of early detection of Alzheimer disease as a follow-up to our Early Detection Webinar. The surveys were developed in collaboration with the Geoffrey Beene Foundation.
View Researcher Survey Results [.pdf].
View Public Survey Results [.pdf].
AlzPossible Initiative
The AlzPossible Initiative is an innovative "center without walls" that enables skilled individuals to share their knowledge about best practices in Alzheimer caregiving through this open forum.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad